Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal ...

The popularity of weight loss drugs has soared during the past few years as new injectable medications have appeared as an effective and safe solution to obesity. But while these drugs may be one of ...

Novo Nordisk CEO Lars Fruergaard Jorgensen testified before the Senate Health, Education, Labor and Pensions Committee hearing in ...

When prescribed for this purpose, the drug is marketed under the name Wegovy, even though it is the same drug as Ozempic. Erik Nelson, owner of Sixth Avenue Pharmacy, said his pharmacy fills ...

Novo Nordisk Chief Executive Lars Jorgensen defended his company's U.S. pricing for the blockbuster drugs Ozempic and Wegovy despite pressure from senators to make the drugs cheaper. The CEO on Tuesda ...